Navigation Links
St. John Hospital 1st in Region to Offer Innovative Chemotherapy Delivery System
Date:11/4/2011

DETROIT, Nov. 4, 2011,  /PRNewswire-USNewswire/ -- A unique treatment involving the use of hot chemotherapy is being offered at St. John Hospital and Medical Center. SJH&MC is the first hospital in Southeast Michigan and one of only approximately 20 centers nationwide to offer the treatment.

Know as Hyperthermic Intraperitoneal Chemotherapy, or HIPEC, the procedure has applications for a number of advanced cancers that have spread to the lining of the abdominal cavity, including colorectal, gastric, ovarian, appendiceal, and mesothelioma. For these patients, chemotherapy through a vein can only give them an additional few months to live.

The treatment involves surgically removing cancerous tumors from the abdominal cavity, then bathing the cavity with hot chemotherapy. The surgeon continuously circulates a heated, sterile chemotherapy solution throughout the abdominal cavity for up to two hours, killing remaining cancer cells without damaging normal cells in the body. The solution is then removed and the incision is closed.

Delivering the heated chemotherapy throughout the abdominal cavity distributes the drug thoroughly and allows it to directly penetrate the areas of cancer and reach areas where cancer cells aren't easily visible. Because the chemotherapy is delivered directly to the tumor, many of the side effects associated with intravenous administration of these powerful drugs can be avoided.

"This procedure has been proven to extend the lives of patient's and improve their quality of life," says Richard Berri, M.D., director of surgical oncology at St. John Hospital and one of only surgeons in the world trained to perform the operation. For many patients with advanced cancers that have spread to the abdominal cavity this is their only viable treatment option. Unlike other cancer treatments that only treat the symptoms of abdominal cancers; HIPEC can actually stop the growth of abdominal cancers."

St. John Hospital and Medical Center's Surgical Oncology Program, led by Dr. Berri, provides the most comprehensive and current surgical evaluation and treatment to patients with malignancies that can be treated surgically, including pancreas, liver, colorectal and stomach cancer. SJH&MC also offers the only Peritoneal Malignancies Program in Michigan to offer HIPEC.


'/>"/>
SOURCE St. John Providence Health System
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
2. Gilbert Hospital Continues Cutting Edge Treatments
3. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
4. New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
5. AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study
6. INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients
7. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
8. Hospital to Hold MRSA Briefing for Media and Community Leaders
9. Arizona Heart Hospital Reaches Settlement Regarding Clinical Research Matter
10. Providence Hospital Study Finds Communication System Leads to Faster Heart Attack Treatment
11. Allegheny General Hospital Performs First Liver Transplant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... 2016  The Parenteral Drug Association, Inc. (PDA), ... manufacturing sterile drug products, today announced the publication ... – With link to Comparison Spreadsheet. The ... U.S. FDA, the EU, the Pharmaceutical Inspection Convention/Scheme ... --> --> PDA,s Global Sterile ...
(Date:2/8/2016)... LONDON , Feb.8, 2016 Cardiovascular ... Summary GlobalData,s Medical Devices sector report, ... 2015" provides an overview of Cardiovascular Surgery Devices ... --> The report provides comprehensive ... of the products at various stages of development. ...
(Date:2/8/2016)... and FAIRFIELD, N.J. , Feb. 8, ... Pharmaceuticals, Inc. (Medimetriks) today announced that they have entered ... commercialization rights for OPA-15406 in the U.S. and ... manufacturing rights.  OPA-15406 is a topical, non-steroidal phosphodiesterase IV ... --> --> In ...
Breaking Medicine Technology:
(Date:2/9/2016)... (PRWEB) , ... February 09, 2016 , ... ... therapy products, announced today the introduction of the newly designed, innovative shoulder wrap. ... and better cold therapy coverage for the injured arm and shoulder to promote ...
(Date:2/9/2016)... (PRWEB) , ... February 09, 2016 , ... i2i Systems, ... of the highest preliminary data vendors in the latest KLAS report, Population Health Management ... has led the developing market for population health management (PHM). The latest KLAS ...
(Date:2/8/2016)... ... February 08, 2016 , ... The Federal Laboratory ... federallabs.org . The site houses a wealth of federal resources that businesses can ... process called technology transfer (T2). As a network of over 300 federal laboratories, ...
(Date:2/8/2016)... , ... February 08, 2016 , ... The Valentine’s Season is famous for gift giving ... significant others that they are loved. This year, for more than 5.6 million Americans ... - just won't be enough to remind them of the lives they’ve led and the ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... and clothing, announced expansion into Canada to provide its range of unique and ... sales office in Quebec City that will provide bilingual customer service and marketing ...
Breaking Medicine News(10 mins):